[HTML] frontiersin.org

[HTML][HTML] Subcortical dopamine and cognition in schizophrenia: Looking beyond psychosis in preclinical models

KA Conn, THJ Burne, JP Kesby - Frontiers in Neuroscience, 2020 - frontiersin.org
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current
antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at …
被引用次数：45 相关文章
[HTML] frontiersin.org

[HTML][HTML] Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models

KA Conn, THJ Burne, JP Kesby - Frontiers in Neuroscience, 2020 - frontiersin.org
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current
antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at …

[引用][C] Subcortical dopamine and cognition in schizophrenia: looking beyond psychosis in preclinical models

KA Conn, THJ Burne, JP Kesby - Frontiers in …, 2020 - espace.library.uq.edu.au
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current
antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at …

Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models

KA Conn, THJ Burne, JP Kesby - Frontiers in Neuroscience, 2020 - research.monash.edu
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current
antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at …

Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models.

KA Conn, THJ Burne, JP Kesby - Frontiers in Neuroscience, 2020 - europepmc.org
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current
antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at …

Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models

KA Conn, THJ Burne, JP Kesby - Dopaminergic Alterations in …, 2021 - books.google.com
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current
antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at …

Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models.

KA Conn, THJ Burne, JP Kesby - Frontiers in Neuroscience, 2020 - search.ebscohost.com
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current
antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at …
[HTML] nih.gov

[HTML][HTML] Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models

KA Conn, THJ Burne, JP Kesby - Frontiers in Neuroscience, 2020 - ncbi.nlm.nih.gov
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current
antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at …

Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models

KA Conn, THJ Burne, JP Kesby - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current
antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at …

Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models.

KA Conn, THJ Burne, JP Kesby - Frontiers in Neuroscience, 2020 - europepmc.org
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current
antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at …